SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-138691
Filing Date
2014-04-10
Accepted
2014-04-10 16:30:44
Documents
5
Period of Report
2014-05-22
Effectiveness Date
2014-04-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d695600ddef14a.htm DEF 14A 328907
2 GRAPHIC g695600g64i72.jpg GRAPHIC 10616
3 GRAPHIC g695600g95j55.jpg GRAPHIC 8747
4 GRAPHIC g695600pc001.jpg GRAPHIC 120412
5 GRAPHIC g695600pc002.jpg GRAPHIC 107857
  Complete submission text file 0001193125-14-138691.txt   671690
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35420 | Film No.: 14757318
SIC: 2834 Pharmaceutical Preparations